Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation

Journal of Controlled Release

Volumn 201, Issue , 2015, Pages 14-21

  Kadonosono, Tetsuya ^a   Yamano, Akihiro ^a   Goto, Toshiki ^a   Tsubaki, Takuya ^a   Niibori, Mizuho ^a   Kuchimaru, Takahiro ^a   Kizaka Kondoh, Shinae ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Cell penetrating peptide; Drug delivery; Extravasation; Neuropilin 1; Protein transduction domain

Indexed keywords

BACTERIOPHAGES; CELL ENGINEERING; CELLS; CYTOLOGY; DRUG DELIVERY; ENDOTHELIAL CELLS; OLIGONUCLEOTIDES; PEPTIDES; POLYPEPTIDES; TUMORS;

CELL PENETRATING PEPTIDES (CPPS); CELL-PENETRATING PEPTIDE; DELIVERY SYSTEMS; EXTRAVASATION; NEUROPILIN-1; PROTEIN TRANSDUCTION DOMAINS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR PERMEABILITY;

PROTEINS;

CELL PENETRATING PEPTIDE; CYCLOPEPTIDE; NEUROPILIN 1; NEUTRALIZING ANTIBODY; VASCULOTROPIN; HYBRID PROTEIN; N-END CYSTEINE PEPTIDE TUMOR-HOMING PEPTIDE; OLIGOPEPTIDE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; EXTRAVASATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TUMOR CELL; TUMOR XENOGRAFT; XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; METABOLISM; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; GENE PRODUCTS, TAT; HUMANS; MALE; MICE, INBRED BALB C; NEOPLASMS; NEUROPILIN-1; OLIGOPEPTIDES; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS;

EID: 84921038666     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.01.011     Document Type: Article

References (32)

1. A.I. Minchinton, and I.F. Tannock Drug penetration in solid tumours Nat. Rev. Cancer 6 2006 583 592
2. J. Fang, H. Nakamura, and H. Maeda The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Deliv. Rev. 63 2011 136 151
3. V. Torchilin Tumor delivery of macromolecular drugs based on the EPR effect Adv. Drug Deliv. Rev. 63 2011 131 135
4. G. Neufeld, T. Cohen, N. Shraga, T. Lange, O. Kessler, and Y. Herzog The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis Trends Cardiovasc. Med. 12 2002 13 19
5. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, O.M. Girard, D. Hanahan, R.F. Mattrey, and E. Ruoslahti Tissue-penetrating delivery of compounds and nanoparticles into tumors Cancer Cell 16 2009 510 520
6. T. Teesalu, K.N. Sugahara, V.R. Kotamraju, and E. Ruoslahti C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration Proc. Natl. Acad. Sci. U. S. A. 106 2009 16157 16162
7. K.N. Sugahara, T. Teesalu, P.P. Karmali, V.R. Kotamraju, L. Agemy, D.R. Greenwald, and E. Ruoslahti Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 328 2010 1031 1035
8. E.E. Paoli, E.S. Ingham, H. Zhang, L.M. Mahakian, B.Z. Fite, M.K. Gagnon, S. Tam, A. Kheirolomoom, R.D. Cardiff, and K.W. Ferrara Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes J. Control. Release 178 2014 108 117
9. L.M. Acevedo, S. Barillas, S.M. Weis, J.R. Gothert, and D.A. Cheresh Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor Blood 111 2008 2674 2680
10. P.M. Becker, J. Waltenberger, R. Yachechko, T. Mirzapoiazova, J.S. Sham, C.G. Lee, J.A. Elias, and A.D. Verin Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability Circ. Res. 96 2005 1257 1265
11. M.W. Parker, P. Xu, X. Li, and C.W. Vander Kooi Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1 J. Biol. Chem. 287 2012 11082 11089
12. M.W. Parker, L.M. Hellman, P. Xu, M.G. Fried, and C.W. Vander Kooi Furin processing of semaphorin 3 F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin Biochemistry 49 2010 4068 4075
13. D. Krilleke, A. DeErkenez, W. Schubert, I. Giri, G.S. Robinson, Y.S. Ng, and D.T. Shima Molecular mapping and functional characterization of the VEGF164 heparin-binding domain J. Biol. Chem. 282 2007 28045 28056
14. A. Antipenko, J.P. Himanen, K. van Leyen, V. Nardi-Dei, J. Lesniak, W.A. Barton, K.R. Rajashankar, M. Lu, C. Hoemme, A.W. Puschel, and D.B. Nikolov Structure of the semaphorin-3A receptor binding module Neuron 39 2003 589 598
15. M.C. Morris, S. Deshayes, F. Heitz, and G. Divita Cell-penetrating peptides: from molecular mechanisms to therapeutics Biol. Cell. 100 2008 201 217
16. F. Heitz, M.C. Morris, and G. Divita Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics Br. J. Pharmacol. 157 2009 195 206
17. M.C. Morris, J. Depollier, J. Mery, F. Heitz, and G. Divita A peptide carrier for the delivery of biologically active proteins into mammalian cells Nat. Biotechnol. 19 2001 1173 1176
18. S.T. Henriques, M.A. Castanho, L.K. Pattenden, and M.I. Aguilar Fast membrane association is a crucial factor in the peptide pep-1 translocation mechanism: a kinetic study followed by surface plasmon resonance Biopolymers 94 2010 314 322
19. A. Mishra, G.H. Lai, N.W. Schmidt, V.Z. Sun, A.R. Rodriguez, R. Tong, L. Tang, J. Cheng, T.J. Deming, D.T. Kamei, and G.C. Wong Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions Proc. Natl. Acad. Sci. U. S. A. 108 2011 16883 16888
20. S. Futaki, H. Hirose, and I. Nakase Arginine-rich peptides: methods of translocation through biological membranes Curr. Pharm. Des. 19 2013 2863 2868
21. A. van den Berg, and S.F. Dowdy Protein transduction domain delivery of therapeutic macromolecules Curr. Opin. Biotechnol. 22 2011 888 893
22. S.R. Schwarze, A. Ho, A. Vocero-Akbani, and S.F. Dowdy In vivo protein transduction: delivery of a biologically active protein into the mouse Science 285 1999 1569 1572
23. T. Kuchimaru, T. Kadonosono, S. Tanaka, T. Ushiki, M. Hiraoka, and S. Kizaka-Kondoh In vivo imaging of HIF-active tumors by an oxygen-dependent degradation protein probe with an interchangeable labeling system PLoS One 5 2010 e15736
24. Y. Fujita, T. Kuchimaru, T. Kadonosono, S. Tanaka, Y. Hase, H. Tomimoto, M. Hiraoka, S. Kizaka-Kondoh, M. Ihara, and R. Takahashi In vivo imaging of brain ischemia using an oxygen-dependent degradative fusion protein probe PLoS One 7 2012 e48051
25. H. Jia, M. Lohr, S. Jezequel, D. Davis, S. Shaikh, D. Selwood, and I. Zachary Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis Biochem. Biophys. Res. Commun. 283 2001 469 479
26. S. Kizaka-Kondoh, S. Itasaka, L. Zeng, S. Tanaka, T. Zhao, Y. Takahashi, K. Shibuya, K. Hirota, G.L. Semenza, and M. Hiraoka Selective killing of hypoxia-inducible factor-1-active cells improves survival in a mouse model of invasive and metastatic pancreatic cancer Clin. Cancer Res. 15 2009 3433 3441
27. C. Gu, B.J. Limberg, G.B. Whitaker, B. Perman, D.J. Leahy, J.S. Rosenbaum, D.D. Ginty, and A.L. Kolodkin Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165 J. Biol. Chem. 277 2002 18069 18076
28. P.G. Frank, S. Pavlides, and M.P. Lisanti Caveolae and transcytosis in endothelial cells: role in atherosclerosis Cell Tissue Res. 335 2009 41 47
29. G. Cao, W. Pei, H. Ge, Q. Liang, Y. Luo, F.R. Sharp, A. Lu, R. Ran, S.H. Graham, and J. Chen In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis J. Neurosci. 22 2002 5423 5431
30. J.F. Liang, and V.C. Yang Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency Biochem. Biophys. Res. Commun. 335 2005 734 738
31. L.N. Patel, J. Wang, K.J. Kim, Z. Borok, E.D. Crandall, and W.C. Shen Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin Mol. Pharm. 6 2009 492 503
32. A.M. Jubb, L.A. Strickland, S.D. Liu, J. Mak, M. Schmidt, and H. Koeppen Neuropilin-1 expression in cancer and development J. Pathol. 226 2012 50 60